Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation & Amortization (IS)EBIATNon-Current ReceivablesOther Gross PP&E AdjustmentsShort-Term Debt issuances
Ratios

Dr Reddys Laboratories (RDY) Receivables Refunds (2018 - 2023)

Historic Receivables Refunds for Dr Reddys Laboratories (RDY) over the last 11 years, with Q1 2023 value amounting to $32.7 million.

  • Dr Reddys Laboratories' Receivables Refunds fell 3908.71% to $32.7 million in Q1 2023 from the same period last year, while for Mar 2023 it was $32.7 million, marking a year-over-year decrease of 3908.71%. This contributed to the annual value of $33.0 million for FY2023, which is 3773.58% down from last year.
  • Latest data reveals that Dr Reddys Laboratories reported Receivables Refunds of $32.7 million as of Q1 2023, which was down 3908.71% from $53.7 million recorded in Q1 2022.
  • Over the past 5 years, Dr Reddys Laboratories' Receivables Refunds peaked at $60.4 million during Q1 2020, and registered a low of $32.7 million during Q1 2023.
  • In the last 5 years, Dr Reddys Laboratories' Receivables Refunds had a median value of $45.0 million in 2019 and averaged $45.8 million.
  • Per our database at Business Quant, Dr Reddys Laboratories' Receivables Refunds soared by 4253.8% in 2022 and then crashed by 3908.71% in 2023.
  • Quarter analysis of 5 years shows Dr Reddys Laboratories' Receivables Refunds stood at $41.9 million in 2019, then soared by 44.39% to $60.4 million in 2020, then tumbled by 37.72% to $37.6 million in 2021, then soared by 42.54% to $53.7 million in 2022, then crashed by 39.09% to $32.7 million in 2023.
  • Its last three reported values are $32.7 million in Q1 2023, $53.7 million for Q1 2022, and $37.6 million during Q1 2021.